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Abstract  
Introduction: African studies have reported high rates of loss to follow up (LTFU) among children in HIV care and treatment centres. Factors 
associated with LTFU may vary across populations. Few studies have been conducted among HIV infected children in care in rural areas of Kenya. 
Methods: this involved children aged less than 15 years on follow up at Kangundo Level 4 Hospital HIV clinic from January 2010 to December 2015. 
We obtained sociodemographic and clinical information from patient files and electronic databases. Univariate and multivariate regression analyses 
were conducted to identify factors predictive of LTFU. Results: a total of 261 HIV-infected children were followed up. The mean age was 10.0 years 
(IQR, 7-13) and median CD4 count of 582cells/ul (IQR 314-984). By December 2015, 171 children (65.5%) remained in active care, 32 (12.3%) 
transferred out, 13 (5%) died, while 45 (17.2%) were classified as LTFU. Out of the 45 children presumed as LTFU, we traced 44 out of the 45 
children (98%) and found that their actual current status was as follows: 33 of the 44 children (75.0%) had dropped out of care (true LTFU). Factors 
strongly predictive of LTFU included low caregiver level of education (HR 2.3, 1.9-3.9, P = 0.001), WHO stage I and II at enrolment (HR 1.6, 1.4-
2.1, P = 0.05). Conclusion: LTFU of HIV infected children was common with an incidence of 32.9 per 1000 child years and occurred early in 
treatment and risk factors included poverty, low caregiver education, male child and early HIV disease stage. 
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The prevalence of HIV in sub-Saharan Africa remains high, with an 
estimate of 34 million people infected. Of the 2.3 million HIV-infected 
children, about 90% are in sub-Saharan Africa making up 10% of 
People Living with HIV (PLHIV) in the region [1]. Although there has 
been an encouraging decline in the number of PLHIV in Kenya, about 
1.6 million people are still infected, with children below 15 years 
making up 12% [2]. Anti Retroviral Therapy (ART) coverage in Kenya 
has significantly expanded over the past decade with 78.4% of those 
requiring ART accessing ART but coverage among children remains 
low with only 32% of those needing ART receiving it [2]. The long-
term success of ART in children depends on adherence to treatment 
and follow-up. This is critical in children, as they will require life-long 
therapy [3] without which HIV disease progresses more rapidly than 
in adults. As ART coverage expands, a rise in loss to follow-up (LTFU) 
has been observed in many ART programmes in Africa and is notably 
worse among children [4]. LTFU is, therefore, a major impediment to 
successful implementation of HIV care and treatment programmes in 
sub-Saharan Africa, with an estimated 20-40% of patients being lost 
to follow up [4]. LTFU is associated with increased risk of ART failure, 
morbidity, mortality and hospitalizations [5]. LTFU among children in 
Kenya has been largely evaluated in research settings in tertiary 
referral hospitals and their catchment areas. In western Kenya, 50% 
of children were found to have ever missed an appointment [6]. 
According to Kenya National Aids and STI Control Programme [7], 
18% of children aged below 10 years and 32% of adolescents are 
LTFU. About 18% of children enrolled in ART programmes in western 
Kenya will be LTFU [8]. Several sociodemographic and clinico-
immunological factors have been reported to contribute to LTFU 
among children in ART programmes. Factors associated with LTFU 
may differ from population to population. A better understanding of 
these factors will help to develop targeted interventions to improve 
retention and predict the risk of LTFU among newly enrolled children 
so as to institute proper measures on initial contact. The aim of the 
present study was to determine the factors predictive of LTFU among 
children enrolled in an HIV care and treatment programme in a rural 





Study design: a cross-sectional was carried out at Kangundo Level 
4 Hospital, which runs an HIV clinic with a total enrolment of 3500 
patients with 300 being children below 15 years of age. LTFU was 
defined as patients who did not return for care or treatment for a 
period of 3 months or more since their most recent documented 
appointment date despite repeated phone contact. 
  
Data collection: the study was approved by Kenyatta National 
Hospital/University of Nairobi Ethics and Review Committee. Physical 
files of all children under care in the HIV clinic between January 2010 
and December 2015 were retrieved from the records office by the 
records officer assisted by the peer counsellors. Case record forms 
were used to capture sociodemographic characteristics such as age, 
gender, caregiver of the child, caregiver education level, HIV status 
of caregiver, whether biological parents were alive and economic 
status of parents or caregivers. Clinical characteristics captured 
included baseline CD4 count, WHO stage at enrolment, ART regimen 
initiated and history of opportunistic infections. Children were 
categorized as active in care, lost to follow-up, dead or transferred 
out. Those lost to follow up were traced physically to determine their 
true status of follow up as either self-transferred out, dead or lost to 
follow up. 
  
Data analysis: data from the questionnaires was entered into SPSS 
Version 23.0, IBM. Descriptive statistics of patients and caregiver 
characteristics were determined. Period prevalence of LTFU and 
incidence rate were calculated. Univariate predictors of LTFU versus 
retention in care were then determined using Chi-square, Fisher's 
exact test and reported as hazard ratios with significance set at 5% 





Between January 2010 and December 2015, a total of 261 children 
were found to be on follow-up at the HIV clinic at Kangundo Level 4 
Hospital. The mean age of the children was 9.98 yrs, (median 10 
years (Interquartile range 7-13) with 57.1% (149) and 42.9% (112) 
males and females respectively. Table 1 summarizes the baseline 
sociodemographic characteristics of the children. The median CD4 
count among the entire cohort of enrolled children was 582 cells/ul. 
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Majority (84.7%) were on ART. The baseline clinical characteristics of 
the children are summarized in Table 2. 
  
Status of follow-up: status of follow-up was categorized as; those 
in active care, dead, transferred out, or loss to follow-up. Over the 
study period, 65.5% (171) of the children continued under active 
care, while 17.2% (45) satisfied the criteria of loss to follow-up. 
Table 3 below summarizes the status of follow-up. 
  
Predictors of loss to follow-up: after univariate analysis, male 
children (p = 0.025), children whose caregivers had low level of 
education (p = 0.001), and child not on ART (p = 0.0001) were 
among the factors found to be significantly correlated with LTFU. 
Below is a tabular demonstration of the factors associated with loss 
to follow up (Table 4). After construction of a multivariate logistical 
regression model we found that low caregiver level of education was 
most predictive of LTFU (p = 0.001). Table 5 illustrates the logistical 
regression model for the selected independent factors associated with 
LTFU. 
  
Status of follow up after tracing: out of the 45 children who were 
lost to follow up, we were able to trace and know the status of 44 of 
them. 33 (75.0%) of the 44 had dropped out of care (True loss to 
follow up), while 6 (13.6%) were dead and 5 (11.4%) had transferred 
to other facilities without referral. The true period prevalence of LTFU 
over the study period was found to be 12.6% (n = 261). The true 





A total of 261 children were followed up during the study period with 
a median age of 10 years, with 57.1% and 42.9% being male and 
female children respectively. The child's primary caregiver was the 
mother in 51.3% of the cases, followed by grandmother in 19.5% of 
cases. In 41.8% of the cases studied, the biological mother was 
deceased, while the father was deceased in 48.7% of the cases. This 
means that a substantial number of the children are under the care 
of grandmothers and relatives, who often have poor socioeconomic 
and education status, fuelling loss to follow-up. This has been 
identified as one of the challenges in the provision of HIV care in 
resource-limited setting [9]. 
  
Magnitude of loss to follow up: the true cumulative incidence was 
32.9 per 1000 child years of LTFU over the study period and the 
periodic prevalence was 12.6%. This magnitude of LTFU of 12.6% is 
in agreement with findings from previous studies conducted in sub-
Saharan Africa. About 21% of patients in HIV programmes are LTFU 
in Africa [10]. LTFU differs radically across populations because 
authors use different definitions. For instance, a Ugandan study 
reported 50.1% of children were LTFU [11], while a South African 
study reported a LTFU rate of 50.2% [12]. Different definitions of 
LTFU carry the inherent risk of misclassification of active patients as 
LTFU. Some studies cite absence of 1 week from a scheduled 
appointment [13], absence of 2 weeks after an appointment date 
[14], while other use 6 weeks of missed appointment [15]. We 
employed the WHO definition of LTFU as more than 90 days absence 
from the missed clinical or drug pick-up appointment without any 
follow up visit [16], a definition also used by NASCOP, Kenya. In 
Kenya, previous studies have focused on HIV programmes in referral 
hospitals or urban centres. Our study is among the very few looking 
at LTFU in rural settings. In a study conducted in Western Kenya, 
14.2% of children were LTFU. For children already initiated on ART, 
14.1% dropped out of care [8]. This shows that the magnitude of 
LTFU in this referral setting does not significantly differ from our study 
in a rural setting. It has been reported that 10-14% of children on 
ART get lost to follow up in HIV care programmes in Africa [8]. 
  
Factors predictive of loss to follow up: male children were more 
likely to be lost to follow up compared to female children. Our finding 
is similar to what has been reported by researchers in South Africa 
[17], Uganda [18] and the KIDS-ART-LINC collaboration study [19]. 
Another study done in Uganda reported a higher incidence of LTFU 
among female children compared to male, although the difference 
was not statistically significant [20]. The reasons for the gender 
difference in LTFU have not been elucidated in the literature and may 
vary across ethnicities. There is need to identify issues facing each of 
the genders and address them specifically. Low caregiver level of 
education was associated with increased LTFU. A similar trend has 
been reported in a Brazilian study conducted in Pernambuco [9]. In 
the current study setting, most of the caregivers were grandmothers, 
as the children were orphaned. These caregivers had little or no 
formal education and are unlikely to understand the importance of 
adherence to clinic appointments. Further, caregivers without formal 
education are more likely to believe in faith healing and use of 
traditional medicine, increasing the likelihood of LTFU [21]. 
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Our study found that 67.4% of the children LTFU were in WHO stages 
I and II. Further, WHO stage I and II was positively correlated with 
LTFU, with children in this stage 1.88 times more likely to be LTFU 
compared with those in stage III and IV. These findings are supported 
by a study conducted in Mozambique [22]. This may be explained by 
the fact that caregivers have the notion that children with early HIV 
disease are not sick, and therefore don't adhere to clinic 
appointments. However, several studies have attributed LTFU to 
severe immunosuppression. In the KIDS-ART-LINC study [19], there 
was a positive correlation between LTFU and severe clinical status 
defined as WHO stages III and IV. Massavon et al. [23] found that 
children in stage III and IV were more likely to be LTFU. Surprisingly, 
children who had biological parents as caregivers were found to be 
more likely to be LTFU. A similar trend was reported in the study, 
wamepotea in western Kenya, where orphans were less likely to be 
LTFU [8]. Many studies have also reported that in cases where the 
biological mother is the primary caregiver, there is a high likelihood 
of LTFU [17, 18]. A possible explanation is that in most cases, the 
mother is HIV positive and may be in denial, too ill to honour clinic 
appointments, or suffering from guilt. Children whose caregivers were 
in informal employment were found be more likely to be LTFU in the 
current study. This may be related to the financial constraints of 
paying for transport from home, as has been found in previous studies 
[3]. A study done in western Kenya found that provision of food to 
child in the HIV clinic appeared to reduce the incidence of LTFU [24]. 
This is because most of the caregivers of these children have 
difficulties providing food and basic amenities to these children, partly 
because of the cost of other opportunistic infections the child may 
have. 
  
We found that children not on ART were more likely to be LTFU. This 
is in agreement with the findings from other studies that have shown 
that LTFU in the pre-ART group is significantly higher than post-ART 
initiation group [25]. In our cohort, majority of children were LTFU in 
the immediate period before 6 months after enrolment. It is possible 
that before initiation of ART, children and caregivers are not 
counselled properly, hence are more likely to be LTFU. Those children 
being started on ART are counselled thoroughly hence are more likely 
to adhere to clinic appointments. For the children LTFU, 44 caregivers 
were successfully traced. Out of the 44 children traced, 33 (71.1%) 
were reclassified as true LTFU, 13.3% were deceased, while 13.3% 
had transferred to other facilities. This mirrors the findings of the 
wamepotea study in western Kenya, where 16% of the traced 
children were found to be deceased [23]. In this study, 11% were 
found to have transferred to other clinics. The finding that some 
children initially classified as LTFU may be deceased means that the 
mortality rate due to HIV may be higher than thought. A study in 
Malawi found that HIV patients LTFU had generally higher mortality 
rate than the general population [26]. This underscores the need for 





Children from lower socio-economic status families whose caregivers 
are of low education and who have early HIV disease at entry of care 
and not on ART are more likely to drop out of care. The caregivers 
with low education level should be given more counselling to ensure 
their understanding of the importance of adhering to clinic 
appointments. 
  
What is known about this topic 
 It is already known that there is high prevalence of loss to 
follow-up among children enrolled in HIV care and 
treatment programmes. 
 Factors associated with loss to follow-up have been 
described in many studies and have been noted to vary 
across populations and countries. 
What this study adds 
 This study elucidates factors associated with loss to follow-
up in a predominantly rural population; 
 It reveals that true loss to follow-up should be declared 
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Table 1: baseline socio-demographic characteristics of children 
Characteristic Frequency % 
Age Group     
<2 yrs 5 1.9 
2-5 years 37 14.1 
6-10 73 28 
11-14 146 56 
Median age       10 IQR(7-13) 
Gender     
Male 149 57.1 
Female 112 42.9 
Child in school     
Yes       239 91.6 
No 20 7.7 
Missing data 2 0.8 
Biological mother alive     
Yes 131 50.2 
No 127 48.7 






Table 2: baseline clinical characteristics of the entire cohort of enrolled children  
Clinical characteristic 
All children enrolled in the clinic 
N % 
WHO stage at enrolment     
Stage I 70 26.8 
Stage II 115 44.1 
Stage III 69 26.4 
Stage IV 2 0.8 
Baseline CD4 count 
Median IQR 
636.5 314-984 
Weight:  WAZ     
0 to -1 107 39.9 
<-1 to -2 126 47.0 
<-2 to -3 33 12.3 
<-3 2 0.8 
Whether on ART     
Yes 221 84.7 
No 33 12.6 
First line ART regimen     
Zidovudine-based 88 23.6 
Abacavir-Based 122 46.7 
Stavudine-Based 6 2.3 
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Retention Status     
Active 171 (65.5) 
Transferred out 32 (12.3) 
Dead 13 (5) 
LTFU 45 (12.3) 
Duration in care in months     
Active 48 24-60 
Transferred out 29 18-36 
Dead 30 27-34 
LTFU 8 4-34 
Among LTFU-Time to LTFU N= 45   
<6 months 16 (35.5) 
6 months-1 year 9 (20) 
1-3 years 12 (26.7) 
>3 yrs 8 (17.8) 




Table 4: univariate analysis of the factors associated with Loss to follow up 
Characteristic 
Lost to Follow-up 
Freq (%) 
Not Lost to Follow-up 
Freq (% ) 
Unadjusted OR (95% CI) 
and P-value 
Gender     
 Male 26 (17.5) 123 (82.5) 
Female 19 (16.8) 93 83.2 
Caregiver level 
of education 
        
2.50 (1.05-4.55), 0.01 
None &Primary 34 (23.4) 111 (76.6) 
Secondary &above 11 (13.3) 72 (86.7) 
WHO stage at 
enrolment 
        
1.88 (0.71-3.22), 0.03 
Stage I and II 36 (18.8) 156 (81.2) 
Stage III and IV 7 (9.7) 65 (90.3) 
Primary caregiver     
1.12 (1.08-3.33), 0.05 Parents 28 (17.9) 128 (82.1) 
Relatives 17 (16.1) 88 (83.9) 
Caregiver source of income     
1.66 (1.182-1.912), 0.039 Informal employment/farmer 42 (19.5) 183 (80.5) 
Formal employment 1 (12.5) 7 (42.5) 








(89.6) 5.83. (4.23-9.76), 0.01 
 No  (57.5) 14 (42.5) 
History of regimen switch     
1.4 (1.0-1.6), 0.05 Yes 3 (6.5) 43 (93.5) 




Table 5: multivariate model of predictors of loss to follow up 
Independent variable Adjusted OR (95% CI) P-Value 
Male gender 1.22 (1.08-2.63) 0.02 
Low caregiver education level 2.30 (1.87-3.94) 0.001 
WHO Stage I & II 1.62 (1.44-2.09) 0.05 
Child not on ART 4.70 (4.43-5.97) 0.03 
 
